Cite
HARVARD Citation
Eufemon Cereno, R. et al. (2023). Should organs at risk (OARs) be prioritized over target volume coverage in stereotactic ablative radiotherapy (SABR) for oligometastases? a secondary analysis of the population-based phase II SABR-5 trial. Radiotherapy and oncology. p. . [Online].